Please assess the completion status of the following clinical trial:

Trial Title: Monitoring Glucose Levels in Patients With Myocardial Infarction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Acute coronary syndrome according to the joint recommendations by the European Society of Cardiology (48, 49)~* Signed written informed consent consistent with Helsinki declaration and local legislations prior to participation in the trial.~Exclusion Criteria:~* \<18 years old.~* Congestive heart failure.~* Patients who, in the opinion of the investigator, will have difficulties to comply with the protocol (examples: alcohol or drug abuse, psychiatric disorder).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Glucose monitoring by OptiScanner® (Type: OTHER): Glucose monitoring and intervention guided by OptiScanner®
- Blinded continuous glucose monitoring (Type: OTHER): Blinded continuous glucose monitoring by OptiScanner® and glucose lowering intervention guided by routine glucose measurements

Based on this trial design, predict the completion outcome and termination type (if applicable).